Association between personality traits and Escitalopram treatment efficacy in panic disorder

References

• Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63:415–24.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet. 2006;368:1023–32.
   PubMed Web of Science ®Google Scholar
• Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol. 1994;103:103–16.
   PubMed Web of Science ®Google Scholar
• Bienvenu OJ, Brown C, Samuels JF, Liang KY, Costa PT, Eaton WW, et al. Normal personality traits and comorbidity among phobic, panic and major depressive disorders. Psychiatry Res. 2001;102:73–85.
   PubMed Web of Science ®Google Scholar
• Bienvenu OJ, Samuels JF, Costa PT, Reti IM, Eaton WW, Nestadt G. Anxiety and depressive disorders and the five-factor model of personality: a higher- and lower-order personality trait investigation in a community sample. Depress Anxiety. 2004;20:92–7.
   PubMed Web of Science ®Google Scholar
• Carrera M, Herrán A, Ramirez ML, Ayestaran A, Sierra-Biddle D, Hoyuela F, et al. Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short-term outcome. Acta Psychiatr Scand. 2006;114:417–25.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, Donker M. Personality traits of patients with mood and anxiety disorders. Psychiatry Res. 2005;133:229–37.
   PubMed Web of Science ®Google Scholar
• Ampollini P, Marchesi C, Signifredi R, Maggini C. Temperament and personality features in panic disorder with or without comorbid mood disorders. Acta Psychiatr Scand. 1997;95:420–3.
   PubMed Web of Science ®Google Scholar
• Võhma Ü, Aluoja A, Vasar V, Shlik J, Maron E. Evaluation of personality traits in panic disorder using Swedish universities Scales of Personality. J Anxiety Disord. 2010;24:141–6.
   PubMed Web of Science ®Google Scholar
• Fiedorowicz JG, Hale N, Spector AA, Coryell WH. Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram. Ann Clin Psychiatry. 2010;22:157–63.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Shirayama Y, Muneoka K, Suzuki M, Sato K, Hashimoto K, Low openness on the revised NEO personality inventory as a risk factor for treatment-resistant depression. PLoS One. 2013;8:e71964
   PubMed Web of Science ®Google Scholar
• Reich JH, Green AI. Effect of personality disorders on outcome of treatment. J Nerv Ment Dis. 1991;179:74–82.
   PubMed Web of Science ®Google Scholar
• Noyes R Jr, Crowe RR, Harris EL, Hamra BJ, McChesney CM, Chaudhry DR. Relationship between panic disorder and agoraphobia. A family study . Arch Gen Psychiatry. 1986;43:227–32.
   PubMed Web of Science ®Google Scholar
• Hofmann SG, Shear MK, Barlow DH, Gorman JM, Hershberger D, Patterson M, et al. Effects of panic disorder treatments on personality disorder characteristics. Depress Anxiety. 1998;8:14–20.
   PubMedGoogle Scholar
• Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study. J Affect Disord. 2005;89:189–94.
   PubMed Web of Science ®Google Scholar
• Marchesi C, De Panfilis C, Cantoni A, Giannelli MR, Maggini C. Effect of pharmacological treatment on temperament and character in panic disorder. Psych Res. 2008;158:147–54.
   PubMed Web of Science ®Google Scholar
• Marchesi C, De Panfilis C, Cantoni A, Fontò S, Gianelli MR, Maggini C. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1240–5.
   PubMed Web of Science ®Google Scholar
• Chavira DA, Stein MB, Golinelli D, Sherbourne CD, Craske MG, Sullivan G, et al. Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder. J Nerv Ment Dis. 2009;197:715–21.
   PubMed Web of Science ®Google Scholar
• Hedman E, Andersson G, Lindefors N, Gustavsson P, Lekander M, Rück C, et al. Personality Change following internet-based cognitive behavior therapy for severe health anxiety. PLoS One. 2014;9:e113871.
   PubMed Web of Science ®Google Scholar
• Neuger J, Wistedt B, Aberg-Wistedt A, Stain-Malmgren R. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients. J Clin Psychopharmacol. 2002;22:400–5.
   PubMed Web of Science ®Google Scholar
• Andrisano C, Balzarro B, Fabbri C, Chiesa A, Serretti A. Antideprressant and panic disorder. Clin Neuropsychiatry. 2012;9:84–101.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weillerr E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.
   PubMed Web of Science ®Google Scholar
• Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154:1571–5.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology. Revised. Washington (DC): US Goverment Printing Office, 1976 DHEW publication ADM 76–338.
   Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5.
   PubMed Web of Science ®Google Scholar
• Aluoja A, Shlik J, Vasar V, Luuk K, Leinsalu M. Development and psychometric properties of the Emotional State Questionnaire, a self-report questionnaire for depression and anxiety. Nord J Psychiatry. 1999;53:443–9.
   Web of Science ®Google Scholar
• Vanderkooy JD, Kennedy SH, Bagby RM. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry. 2002;47:174–80.
   PubMed Web of Science ®Google Scholar
• Furukawa TA, Shear MK, Barlow DH, Gorman JM, Woods SW, Money RM, et al. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depress Anxiety. 2009;26:922–9.
   PubMed Web of Science ®Google Scholar
• Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Bilt JV, et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res. 2001;35:293–6.
   PubMed Web of Science ®Google Scholar
• Park HU, Kim EJ, Ku JI, Woo JM, Lee SH, Chung SK, et al. Psychological characteristics of early remitters in patients with panic disorder. Psychiatry Res. 2012;197:237–41.
   PubMed Web of Science ®Google Scholar
• Seki Y, Nagata S, Shibuya T, Yoshinaga N, Yokoo M, Ibuki H, et al. A feasibility study of the clinical effectiveness and cost-effectivenessof individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study. BMC Res Notes. 2016;9:458.
   PubMedGoogle Scholar
• Schalling D. Psychopathy-related personality variables and the psychophysiology of socialization. In: Hare RD, Schalling D, editors. Psychopathic behaviour.approaches to research. Chichester: John Wiley and Sons; 1978, p. 85–106.
   Google Scholar
• Gustavsson JP, Bergman H, Edman G, Ekselius L, von Knorring L, Linder J. Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data. Acta Psychiatr Scand. 2000;102:217–25.
   PubMed Web of Science ®Google Scholar
• Aluoja A, Voogne H, Maron E, Gustavsson JP, Võhma Ü, Shlik J. Personality traits measured by Swedish universities Scales of Personality: factor structure and position within the five-factor model in an Estonian sample. Nord J Psychiatry. 2009;63:231–6.
   PubMed Web of Science ®Google Scholar
• Fagerberg T, Söderman E, Gustavsson JP, Agartz I, Jönsson EG. Personality traits in esatablished schizophrenia: asects of usability and diferences between patients and controls using the Swedish universities Scales of Personality. Nord J Psychiatry. 2016;70:462–9.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2014. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing,.
   Google Scholar
• Barratt ES. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep. 1965;16:547–54.
   PubMed Web of Science ®Google Scholar
• Askenazy F, Caci H, Myquel M, Darcourt G, Lecrubier Y. Relationship between impulsivity and platelet serotonin content in adolescents. Psychiatry Res. 2000;94:19–28.
   PubMed Web of Science ®Google Scholar
• Apter A, Plutchik R, van Praag HM. Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand. 1993;87:1–5.
   PubMed Web of Science ®Google Scholar
• Lecrubier Y, Braconnier A, Said S, Payan C. The impulsivity rating scale (IRS): preliminary results. Eur Psychiatry. 1995;10:331–8.
   PubMed Web of Science ®Google Scholar
• Caci H, Askenazy F, Frequelin N, Nadalet L, Myquel M, Staccini P, et al. Validation of the Impulsivity Rating Scale and relationship with anxiety in healthy French adolescents. Int J Methods in Psychiatr Res. 1998;7:128–35.
   Google Scholar
• Summerfeldt LJ, Hood K, Antony MM, Richter MA, Swinson RP. Impulsivity in obsessive–compulsive disorder: comparisons with other anxiety disorders and within tic-related subgroups. Pers Individ Differ. 2004;36:539–53.
   Web of Science ®Google Scholar
• Del Carlo A, Benvenuti M, Fornaro M, Toni C, Rizzato S, Swann AC, et al. Different measures of impulsivity in patients with anxiety disorders: a case control study. Psychiatry Res. 2012;197:231–6.
   PubMed Web of Science ®Google Scholar
• Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Jimenesz M, et al. Fluoxetine response in impulsive-agressive behavior and serotonin transporter polmorfism in personality disorder. Psychiatr Genet. 2010;20:25–30.
   PubMed Web of Science ®Google Scholar
• Walderhaug E, Herman AI, Magnusson A, Morgan MJ, Landrø NI. The short (S) allele of the serotonin transporter polymorphism and acute tryptophan depletion both increase impulsivity in men. Neurosci Lett. 2010;473:208–11.
   PubMed Web of Science ®Google Scholar
• Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1:131–9.
   PubMed Web of Science ®Google Scholar
• Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry. 1982;139:741–6.
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46:587–99.
   PubMed Web of Science ®Google Scholar
• O’Keane VO, Moloney E, O’Neill H, O’Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 1992;160:643–6.
   PubMed Web of Science ®Google Scholar
• Maron E, Tõru I, Hirvonen J, Tuominen L, Lumme V, Vasar V, et al. Brain serotonin transporter availability in panic disorder: gender differences and implications for treatment response to escitalopram. J Psychopharmacol. 2010;25:952–9.
   PubMed Web of Science ®Google Scholar
• Nash JR, Sargent AP, Rabiner EA, Hood SD, Argyropoulos SV, Poyokar JP, et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. B J Psychiatry. 2008;193:229–34.
   PubMed Web of Science ®Google Scholar
• Cannon DM, Klaver JM, Klug SA, Carlson PJ, Luckenbaugh DA, Ichise M, et al. Gender-specific abnormalities in the serotonin transporter system in panic disorder. Int J Neuropsychopharmacol. 2013;16:733–43.
   PubMed Web of Science ®Google Scholar